Scytera

Manufacturer
DPT Laboratories, Ltd.
Effective date
2009-08-18
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:22:33

Label at a glance#

ProductScytera (coal tar) Foam, 2%
Active ingredientCOAL TAR
Label structure18 sections

Dosage and administration

shake the can well before use. invert the can to dispense. Upright dispensing will cause loss of propellant. apply to affected areas one to four times daily or as directed by a doctor.

Label contents#

Full prescribing information#

DESCRIPTION SECTION

Scytera™ Foam is an emollient foam containing 10% coal tar topical solution (Liquor Carbonis Detergens) equivalent to 2% coal tar.

Active Ingredient - Purpose

OTC - ACTIVE INGREDIENT SECTION

Active ingredient: Coal Tar 2% (from Coal Tar Topical Solution USP, 10%)
Purpose: Psoriasis

Use

OTC - PURPOSE SECTION

For relief of the symptoms of psoriasis.

Warnings

WARNINGS SECTION

For external use only.

Flammable

Avoid fire, flame, or smoking during and immediately following application.

Do not use

OTC - DO NOT USE SECTION

  • for prolonged periods without consulting a doctor
  • this product in or around the rectum or in the genital area or groin except on the advice of a doctor

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

a condition that covers a large area of your body.

Ask a doctor or pharmacist before use if you are

OTC - ASK DOCTOR/PHARMACIST SECTION

using the product with other forms of psoriasis therapy such as ultraviolet radiation or prescription drugs.

When using this product

OTC - WHEN USING SECTION

  • avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.
  • use caution in exposing skin to sunlight after applying this product. It may increase your tendency to sunburn for up to 24 hours after application.
  • product can stain clothing, contact lenses, and hair. To minimize staining, allow product to dry before contact.

Stop use and ask doctor if

OTC - STOP USE SECTION

condition worsens or does not improve after regular use of this product as directed.

If pregnant or breastfeeding

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a poison control center right away.

Directions

INDICATIONS & USAGE SECTION

  • shake the can well before use.
  • invert the can to dispense. Upright dispensing will cause loss of propellant.
  • apply to affected areas one to four times daily or as directed by a doctor.

Other information

SPL UNCLASSIFIED SECTION

  • contents under pressure. Do not puncture or incinerate.
  • store at 68°F to 77°F (20°C to 25°C)
  • do not expose to heat or store at temperatures above 120°F (49°C)

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Caprylic/capric triglyceride, ceteareth 20, citric acid, cyclomethicone, dimethicone, EDTA disodium, glycerin, hydroxypropyl methyl cellulose, isopropyl myristate, peppermint oil, phenoxyethanol, potassium sorbate, purified water, sodium citrate, stearic acid, xanthan gum, hydrocarbon (propane/butane) propellant. 

Questions?

OTC - QUESTIONS SECTION

1-888-966-8766

WARNINGS SECTION

Warning
This product contains chemicals known to the state of California to cause cancer.



Patent Pending
Made in USA.
Marketed by:
Promius Pharma, LLC
Bridgewater, NJ 08807
Under license from
Foamix LTD, Israel

Scytera™ (Coal Tar)Foam 2%, 100 g

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Carton and Can Label

NDC 67857-801-52
Psoriasis Foam

Scytera™
(Coal Tar) Foam 2%

Promius Pharma
™
NET WT. 3.3 oz (100 g)
Scytera_Carton_100_01
Scytera_Carton_100_01
Scytera_Can_100_01
Scytera_Can_100_01


Carton (California)

NDC 67857-801-26
Psoriasis Foam

Scytera™
(Coal Tar) Foam 2%

Promius Pharma
™
NET WT. 3.3 oz (100 g)
Scytera_CA_Carton_100_01
Scytera_CA_Carton_100_01



Scytera™ (Coal Tar)Foam 2%, 12 g Sample Size

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Packer (Box)

Available in 100 g Cans

Scytera™
(Coal Tar) Foam 2%
Promius Pharma™

Professional Samples


Net Quantity 12 x 12 g Cans
NDC 67857-801-12
Scytera_Carton_12_01
Scytera_Carton_12_01


Packer (Box) (California)

Available in 100 g Cans

Scytera™
(Coal Tar) Foam 2%
Promius Pharma™

Professional Samples


Net Quantity 12 x 12 g Cans
NDC 67857-801-19
Scytera_CA_Carton_12_01
Scytera_CA_Carton_12_01


Can Label

NDC 67857-801-12
Psoriasis Foam

Scytera™
(Coal Tar) Foam 2%

SAMPLE, NOT FOR SALE

NET WT. 0.4 oz (12 g)

Scytera_Can_12_01
Scytera_Can_12_01

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
824335crude coal tar 2 % Topical FoamPSN1
824921Scytera 2 % Topical FoamPSN1
824921coal tar 20 MG/ML Topical Foam [Scytera]SBD1
824335coal tar 20 MG/ML Topical FoamSCD1
824335coal tar 2 % Topical FoamSY1
824335crude coal tar 2 % (coal tar solution 10 % ) Topical FoamSY1
824921Scytera (crude coal tar 2 % (coal tar solution 10 % )) Topical FoamSY1
824921Scytera 2 % Topical FoamSY1
824921Scytera 20 MG/ML Topical FoamSY1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63094-0801-1Scytera(coal tar) Foam, 2%1 in 1 CARTONAEROSOL, FOAM11
63094-0801-1Scytera(coal tar) Foam, 2%100 g in 1 CANAEROSOL, FOAM1001
63094-0801-2Scytera(coal tar) Foam, 2%12 g in 1 CANAEROSOL, FOAM121
63094-0801-2Scytera(coal tar) Foam, 2%12 in 1 BOXAEROSOL, FOAM121
63094-0801-3Scytera(coal tar) Foam, 2%1 in 1 CARTONAEROSOL, FOAM11
63094-0801-4Scytera(coal tar) Foam, 2%12 in 1 BOXAEROSOL, FOAM121

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
63094-0801SCYTERA (COAL TAR) FOAM, 2% (COAL TAR FOAM, 2%) AEROSOL, FOAM [DPT LABORATORIES, LTD.]1Legacy NDC, 6 package rows20090819_3637ca89-694d-4061-a23d-e691093276e7.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
COAL TARACTIVE INGREDIENTR533ESO2EC1
COAL TARACTIVE MOIETYR533ESO2EC1
CITRIC ACID MONOHYDRATEINACTIVE INGREDIENT2968PHW8QP1
EDETATE DISODIUMINACTIVE INGREDIENT7FLD91C86K1
GLYCERININACTIVE INGREDIENTPDC6A3C0OX1
HYPROMELLOSEINACTIVE INGREDIENT3NXW29V3WO1
ISOPROPYL MYRISTATEINACTIVE INGREDIENT0RE8K4LNJS1
PEPPERMINT OILINACTIVE INGREDIENTAV092KU4JH1
PHENOXYETHANOLINACTIVE INGREDIENTHIE492ZZ3T1
POTASSIUM SORBATEINACTIVE INGREDIENT1VPU26JZZ41
SODIUM CITRATEINACTIVE INGREDIENT1Q73Q2JULR1
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65AP1
WATERINACTIVE INGREDIENT059QF0KO0R1
XANTHAN GUMINACTIVE INGREDIENTTTV12P4NEE1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
63094-080163094-0801-1, 63094-0801-2, 63094-0801-3, 63094-0801-4

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 13 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 7 · 386 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
XANTHAN GUMXANTHAN GUMTTV12P4NEEPASTE / ORAL1050 mgExact identifier — unii candidate
29 equally ranked IID candidates
POTASSIUM SORBATEPOTASSIUM SORBATE1VPU26JZZ4TABLET / ORAL6 mgExact identifier — unii candidate
19 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APTABLET / ORAL336 mgExact identifier — unii candidate
26 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / AURICULAR (OTIC)63.64 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
ISOPROPYL MYRISTATEISOPROPYL MYRISTATE0RE8K4LNJSOIL / AURICULAR (OTIC)36 mgExact identifier — unii candidate
18 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUPPOSITORY / RECTAL440 mgExact identifier — unii candidate
75 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APIMPLANT / SUBCUTANEOUS1.04 mgExact identifier — unii candidate
26 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEESUSPENSION / OPHTHALMIC2 mgExact identifier — unii candidate
29 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KSOLUTION / TOPICAL1 mgExact identifier — unii candidate
77 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KINJECTION / INTRA-ARTICULAR0.05 %w/vExact identifier — unii candidate
77 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KSOLUTION / INTRAVENOUS0.05 %w/vExact identifier — unii candidate
77 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KTABLET, EXTENDED RELEASE / ORAL10 mgExact identifier — unii candidate
77 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KINJECTION / SUBCUTANEOUS6 mgExact identifier — unii candidate
77 equally ranked IID candidates
POTASSIUM SORBATEPOTASSIUM SORBATE1VPU26JZZ4PASTE / ORAL48 mgExact identifier — unii candidate
19 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPINJECTION / INTRA-ARTICULARADJ PHExact identifier — unii candidate
88 equally ranked IID candidates
HYPROMELLOSEHYPROMELLOSE3NXW29V3WOSUSPENSION / OPHTHALMIC0.5 %w/wExact identifier — unii candidate
27 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUSPENSION / OPHTHALMIC58 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXTABLET / ORAL42 mgExact identifier — unii candidate
75 equally ranked IID candidates
ISOPROPYL MYRISTATEISOPROPYL MYRISTATE0RE8K4LNJSOIL / TOPICAL213 mgExact identifier — unii candidate
18 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPSYRUP / ORAL722 mg/5mlExact identifier — unii candidate
88 equally ranked IID candidates
POTASSIUM SORBATEPOTASSIUM SORBATE1VPU26JZZ4SUSPENSION / ORAL400 mgExact identifier — unii candidate
19 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSHAMPOO / TOPICAL5 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APTABLET, FILM COATED, EXTENDED RELEASE / ORAL120 mgExact identifier — unii candidate
26 equally ranked IID candidates
HYPROMELLOSEHYPROMELLOSE3NXW29V3WOSYSTEM / TOPICAL54 mgExact identifier — unii candidate
27 equally ranked IID candidates
POTASSIUM SORBATEPOTASSIUM SORBATE1VPU26JZZ4TABLET, FILM COATED, EXTENDED RELEASE / ORAL0.2 mgExact identifier — unii candidate
19 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPSUSPENSION / RESPIRATORY (INHALATION)0.03 %w/vExact identifier — unii candidate
88 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPINJECTION / INTRAVENOUS2068 mgExact identifier — unii candidate
88 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPINJECTION, POWDER, FOR SOLUTION / INTRAMUSCULARNAExact identifier — unii candidate
88 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSUSPENSION / AURICULAR (OTIC)0.05 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS225 mgExact identifier — unii candidate
75 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APTABLET, EXTENDED RELEASE / ORAL200 mgExact identifier — unii candidate
26 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KSHAMPOO, SUSPENSION / TOPICAL1 %w/wExact identifier — unii candidate
77 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / TOPICAL1971 mgExact identifier — unii candidate
75 equally ranked IID candidates
XANTHAN GUMXANTHAN GUMTTV12P4NEETABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL36 mgExact identifier — unii candidate
29 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KSPRAY / RESPIRATORY (INHALATION)0.05 %w/wExact identifier — unii candidate
77 equally ranked IID candidates
POTASSIUM SORBATEPOTASSIUM SORBATE1VPU26JZZ4TABLET, EXTENDED RELEASE / ORAL0.2 mgExact identifier — unii candidate
19 equally ranked IID candidates
PEPPERMINT OILPEPPERMINT OILAV092KU4JHGUM, CHEWING / BUCCAL526 mgExact identifier — unii candidate
21 equally ranked IID candidates
HYPROMELLOSEHYPROMELLOSE3NXW29V3WOSYRUP / ORAL250 mgExact identifier — unii candidate
27 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPINJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR38 mgExact identifier — unii candidate
88 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXCAPSULE, EXTENDED RELEASE / ORAL265 mgExact identifier — unii candidate
75 equally ranked IID candidates
HYPROMELLOSEHYPROMELLOSE3NXW29V3WOTABLET, EXTENDED RELEASE / ORAL1472 mgExact identifier — unii candidate
27 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KINJECTION / SOFT TISSUE0.05 %w/vExact identifier — unii candidate
77 equally ranked IID candidates
PEPPERMINT OILPEPPERMINT OILAV092KU4JHSOLUTION / ORAL53 mgExact identifier — unii candidate
21 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXEMULSION / INTRAVENOUS2.2 %w/vExact identifier — unii candidate
75 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KCREAM / TOPICAL14 mgExact identifier — unii candidate
77 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSPRAY / NASAL22.3 mg/1mlExact identifier — unii candidate
75 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KINJECTION, SOLUTION / SUBCUTANEOUS2 mgExact identifier — unii candidate
77 equally ranked IID candidates
PEPPERMINT OILPEPPERMINT OILAV092KU4JHFILM, SOLUBLE / BUCCAL3 mgExact identifier — unii candidate
21 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXGEL / TRANSDERMAL500 mgExact identifier — unii candidate
75 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXCAPSULE, LIQUID FILLED / ORAL185 mgExact identifier — unii candidate
75 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPSOAP / TOPICAL0.5 %w/wExact identifier — unii candidate
88 equally ranked IID candidates
POTASSIUM SORBATEPOTASSIUM SORBATE1VPU26JZZ4AEROSOL, FOAM / TOPICAL8 mgExact identifier — unii candidate
19 equally ranked IID candidates
ISOPROPYL MYRISTATEISOPROPYL MYRISTATE0RE8K4LNJSSYSTEM / TOPICAL7 mgExact identifier — unii candidate
18 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPINJECTION / INTRACARDIAC1.05 %w/vExact identifier — unii candidate
88 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KSPRAY, METERED / NASAL4 mgExact identifier — unii candidate
77 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPFILM / SUBLINGUAL10 mgExact identifier — unii candidate
88 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPSPRAY, METERED / NASAL2 mgExact identifier — unii candidate
88 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPSOLUTION / BUCCALNAExact identifier — unii candidate
88 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KEMULSION / OPHTHALMIC0.3 %w/vExact identifier — unii candidate
77 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXINJECTION / SUBCUTANEOUS450 mgExact identifier — unii candidate
75 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
3637ca89-694d-4061-a23d-e691093276e73637ca89-694d-4061-a23d-e691093276e72009-08-18WarningsExact identifier
spl id: 3637ca89-694d-4061-a23d-e691093276e7
spl set id: 3637ca89-694d-4061-a23d-e691093276e7

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.